Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GW472467X is an experimental small molecule compound with the chemical formula C19H35N3O6S and a molecular weight of approximately 433.56 g/mol[7][10]. It is not approved for use in any country and has no known clinical indications or completed clinical trials as of now[7]. The detailed mechanism of action, biological targets, and therapeutic area have not been disclosed in public databases. The compound was assigned a DrugBank ID (DB08644) but remains at the preclinical or early research stage with no evidence of progression to human studies[7][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on GW472467X.